Background
==========

Neurofibromatosis type 1 (also known as von Recklinghausen disease) is an autosomal dominant disorder with a prevalence of 1 in 3500, and is characterized by hyperpigmented skin macules (café au lait spots), iris tumors (Lisch nodules), and benign tumors of nerve cells (neurofibromas) \[[@B1]\]. Other physical complications observed in NF1 patients include optic pathway gliomas, scoliosis, macrocephaly, epilepsy, chronic headaches, bending of the long bones (pseudoarthrosis), and sphenoid wing dysplasia \[[@B2]\]. Cognitive deficits in spatial learning and memory also accompany these more physical manifestations of NF1 \[[@B3]\]. Though mental retardation is not commonly seen in NF1 patients, a high proportion of children afflicted with NF1 show learning disabilities (30 -- 65%) \[[@B3]\]. These children perform poorly on tasks requiring developed spatial memory and visual-spatial functioning. Though the cognitive manifestations of NF1 have been characterized, no substantial link between the genetic and cognitive deficits has been formed. In addition, no link has been shown between specific mutations within the causative gene and the degree of physical and mental impairment.

NF1 is caused by a heterozygous loss of function mutation within the *NF1*gene located on chromosome 17q11.2. The NF1 gene encodes a ubiquitously expressed cytoplasmic protein called neurofibromin. The suspected function of neurofibromin is based on sequence homology to known GTPase Activating Proteins (GAPs) as well as through cell biological and functional studies of mutant neurofibromin \[[@B4]\]. Neurofibromin inactivates Ras (Ras-GTP) by converting it to Ras-GDP. Loss of neurofibromin within a cell would thus result in constitutive activation of the Ras signaling pathway, ultimately resulting in cell growth. Ras signaling has also been implicated in neuronal activity and synaptic plasticity \[[@B5]\].

It has been hypothesized that neurofibromin may also act as a modulator of adenylyl cyclase or may facilitate microtubule binding \[[@B5]\]. Studies in drosophila, cultured murine neurons, and *Nf1*^-/-^mouse embryos (E12.5) have shown that neurofibromin is necessary for the activation of adenylyl cyclase by pituitary adenylate cyclase activating peptide (PACAP) \[[@B6]-[@B9]\]. *Drosophila*models deficient for neurofibromin have also been used to determine if the learning deficits seen within mammalian samples are caused by the developmental abnormalities seen in NF1 or if the cognitive defects are due directly to decreased neurofibromin activity. Heat-shock induced neurofibromin was expressed in adult *NF1*^-/-^fruit flies, rescuing the learning deficits, indicating that developmental factors are not causing the cognitive deficits \[[@B10]\]. Heat-shock induced cAMP dependent protein kinase (PKA) expression also rescued the learning deficits in adult *NF1*^-/-^fruit flies, indicating that the cellular defect must be upstream of PKA within the adenylate cyclase signaling pathway \[[@B10]\]. In this *Drosophila*model it is hypothesized that neurofibromin acts as a GAP specific to G-proteins, influencing the interaction between G-proteins and adenylate cyclase \[[@B10]\]. The elucidation of auxiliary functions of neurofibromin can be facilitated by further study of such model organisms containing targeted mutations of the *Nf1*gene (*Drosophila*and murine systems).

A mouse model of the cognitive deficits associated with Neurofibromatosis type 1 was first developed in 1994 and has since been utilized in the investigation and characterization of the disease \[[@B11],[@B12]\]. The learning deficits seen in the *Nf1*^+/-^mice include difficulties in spatial learning and decreased hippocampal long-term potentiation (LTP) \[[@B5]\]. Increased levels of GABA-mediated inhibition have been linked to these cognitive deficits within the mouse model and introduction of a GABA~A~receptor antagonist (Picrotoxin) into the knockout mouse system restores normal LTP in the hippocampus \[[@B5]\]. Double knockout mice heterozygous for mutations in both the *Nf1*and *K-ras*genes (*Nf1*^+/-^/*K-ras*^+/-^) show similar performance on the hidden water maze task as wildtype mice \[[@B5]\]. Inactivating mutations within the *K-ras*gene decrease the level of functional Ras protein within the cells. Observations that the combination of *Nf1*and *K-ras*mutations in mice results in normal cognitive function support the link between an increase in Ras activity and visual-spatial learning deficits. Ras activity within cells can also be modulated through the introduction of farnesyl-transferase inhibitors. By blocking the post-translational farnesylation of Ras protein in the *Nf1*^+/-^mutant mice, performance on visual-spatial tasks are comparable to wildtype mice, rescuing the phenotype \[[@B5]\].

The detailed mechanism by which diminished function of neurofibromin protein leads to defects in hippocampal long term potentiation, and subsequent deficits in cognition and learning is not fully understood. Some of the intermediate steps are dependent on gene transcription and new protein synthesis \[[@B13]\]. It is thus appropriate to study the cumulative effect of *Nf1*gene mutation in the developing hippocampus, and characterize alterations in gene expression profiles in this model system. Here we describe the results of our studies comparing gene expression profiles in the hippocampi of *Nf1*^+/-^and wild type mice at postnatal ages 10, 15, and 20 days, a time period that is critical for syanptogenesis and synaptic remodeling in the hippocampus. Application of new high-resolution genomic technologies to the *Nf1*knock-out mouse model may provide new insight into the mechanisms behind the cognitive impairment in humans with Neurofibromatosis type 1.

Results
=======

Genes showing fold change values of ≥2.0 and corresponding p-values of ≤0.05 were visualized across the time series (post natal days 10, 15, and 20) (Fig. [1](#F1){ref-type="fig"}). Figure [1](#F1){ref-type="fig"} shows the expression profiles of genes across the time series and includes only genes which are significantly changed at a minimum of one time point. Individual lists of genes significantly changed at each individual time point are contained in Tables [1](#T1){ref-type="table"}, [2](#T2){ref-type="table"}, and [3](#T3){ref-type="table"}. Four genes were dysregulated at more than one time point: Ate1, Tcfap2d, Rad51l1, Arhgap8. The lists of dysregulated genes include a myriad of genes including enzymes, receptors, channel molecules, and transcription factors. All raw expression data is publicly available \[[@B14],[@B15]\].

RT-PCR validation was performed on a select group of genes showing significantly (p ≤ 0.05) regulated fold changes of ≥2 fold. As can be seen in Table [4](#T4){ref-type="table"}, Affymetrix microarray fold change values correlate well with the trend of transcript levels calculated through RT-PCR reactions. Though the exact fold change values are not identical, the two assays show consistent trends of regulation.

Genes significantly dysregulated at post natal days 10, 15, and 20 were entered into the GeneGo network developing program, along with proteins known to be involved in learning and memory (Tab, ErbB-2, CREB, calcium, AMPA, SH2, ShcC, NMDA receptor, TrkB, MAPK, CaM Kinase II, calcineurin, Rho-associated kinase, MAP2, peripherin, ERK1, ERK2, TARP, PAK3) \[[@B16]\]. A functional network was created identifying genes within the data set that are linked to these known mediators of long term potentiation (LTP).

As expected, the GeneGo networking software identified direct modulation of Ras activity (here notated H-Ras) by neurofibromin. The networking program also identified neurofibromin as a physical binding partner with both the kinesin heavy chain and amyloid beta precursor protein (APP) (Fig. [2](#F2){ref-type="fig"}). While no significant dysregulation of APP was seen in the data set, members of the kinesin motor protein family were downregulated in the *Nf1*^+/-^mice at post natal days 15 and 20 (Tables [2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}).

Gene expression analysis shows a 2.7 fold increase in the expression of dopamine 3 receptor in *Nf1*^+/-^brains at post natal day 15. The GeneGo network development software highlights binding properties between this dopamine receptor and filamin A, a protein involved in cytoskeleton organization through binding with integrins, receptors, and second messengers \[[@B17]\]. The associations between integrins and filamin A and between integrins and APP seen in the GeneGo network links neurofibromin to the dopamine receptor. Here it is hypothesized that the APP and integrin proteins are essential for the transport of the dopamine receptor protein down the axon via the filamin proteins. Several other genes linked to intracellular structure and protein trafficking were also dysregulated in the dataset. Aberrant movement of these complexes within the neurons could lead to abnormal localization or abundance of receptors in neuronal processes.

Discussion
==========

Learning and memory deficits observed in human Neurofibromatosis type 1 patients have been modeled in a *Nf1*gene knock-out murine system showing well characterized spatial learning and memory deficiencies. These mutant mice exhibit increased levels of activated Ras (Ras-GTP) and increased GABA mediated inhibition. Research has shown that the cognitive deficit in this mouse model can be rescued by inactivating Ras (through genetic modification or pharmacological treatment) or by blocking postsynaptic GABA uptake \[[@B5]\].

We used gene expression profiling to investigate the genetic pathways leading to GABA mediated inhibition, and to link deficiency of neurofibromin to long term changes at the synapse. Differentially regulated genes at postnatal days 10, 15, and 20 were analyzed using GeneGo networking software. This network analysis identified direct interactions between NF1, APP, integrins, filamins, and kinesins. Though compound binding properties were identified *in silico*, these interactions must be investigated within the cells including how these interactions affect the activity of each protein or the localization of the proteins with the cell. It is known that kinesin proteins act within the nerve cell to carry proteins and cellular organelles from the cell body down neuronal processes \[[@B18]\]. Interaction between neurofibromin and kinesins suggests a mechanism for intracellular localization of the neurofibromin/APP complex. Current literature has identified physical interactions between NF1, APP, and kinesin-1 integral to vesicle transport in melanocytes and neurons. This study proposed that NF1 gene mutations impair vesicle trafficking through aberrant kinesin transport of both NF1 and APP \[[@B19]\].

Through network analysis an interaction between APP and the dopamine 3 receptor (DRD3) was idenified. DRD3, a member of the G alpha inhibitory G protein coupled receptor family, was also dysregulated in the mutant mice, showing a 3 fold increase in expression in the hippocampus. The DRD3 receptor is a member of the D2 like dopamine receptor superfamily which selectively mediates inhibition of adenylate cyclase V \[[@B20]\]. The DRD3 receptor expression has been localized to limbic areas of the brain, where it acts via the G~o~subunit and adenylate cyclase to decrease cAMP levels \[[@B20],[@B21]\]. It is unknown if alterations in expression of these receptors are involved in either GABA mediated inhibition, or in other pathways leading to the phenotypic leaning and memory deficits characteristic of NF1.

The results of our network analysis are shown in Figure [2](#F2){ref-type="fig"}, implying a functional connection between neurofibromin and the amyloid beta precursor protein/integrin/filamin complex, which is in turn related to the dopamine receptors (Drd3). These potential interactions between neurofibromin and APP or DRD3 might lead to new ideas about how neurofibromin is involved in cellular signaling and synaptic plasticity. Future research should include studies of APP and related signaling pathways as well as dopaminergic systems in NF1 models. This also raises the possibility of investigating these pathways in human patients using modern imaging modalities (such as positron emission tomography).

Methods
=======

Animals (breeding, dissection, genotyping, and sexing)
------------------------------------------------------

*Nf1*^+/-^mice were purchased from Jackson Laboratory (symbol *Nf1*^*tm*1*Fcr*^) \[[@B22]\]. Breeder pairs were allowed to mate, and offspring were collected at postnatal days 10, 15, and 20. At these ages, mice were euthanized and bilateral brain regions (hippocampus, cerebral cortex, cerebellum, olfactory bulb, and basal ganglion/thalamus) dissected and immediately flash frozen in an ethanol/dry ice bath. Liver and blood were also collected from each mouse. All tissues were stored at -80°C until RNA or DNA extraction was performed.

The *Nf1*^+/-^mice contain a Neo targeting cassette, which disrupts the *Nf1*gene to form the knockout allele and can be tested using primers specific for this insert. Genotyping was performed through a series of PCR reactions containing one microliter (approximately 100 ng) of sample DNA, 10 pM of primers, 1× PCR buffer, 2.25 mM MgCl~2~, 10 mM of each dNTP, and 1 unit of Taq Gold polymerase. The PCR cycling program started with 95°C for 5 minutes followed by 35 cycles of 94°C for 1 minute, 55°C for 1 minute, and 72°C for 1 minute. The final step was 72°C for 10 minutes followed by a 4°C hold. Genotyping and sexing primers included:

Control primers (1.2 kilobase product):

mMeC.U256 Forward 5\'-GTATGATGACCCCACCTTGC

mMeC.L1452 Reverse 5\'-TTCAGTCCCTTCCCGCTTTT

Neo specific primers (2 kilobase product):

Neo5\' Forward 5\'-GCGTGTTCGAATTCGCCAATG

Exon 32 Reverse 5\'-GAAGGACAGCATCAGCATG

Y Chromosome specific primers (200 base pair product):

STS162400 Forward 5\'GCAAACAACCTCATAGTCCC

STS162400 Reverse 5\'CTGGATTTGTGACAAGGAGC

The reaction product was visualized by 2% agarose gel electrophoresis and the presence of bands noted. The control PCR reaction detected a segment of the MeCP2 gene on the X chromosome, and was used to monitor the integrity of template genomic DNA, and the amplification reaction. The presence of a single 2 kb band in the Neo specific reaction indicated a *Nf1*^+/-^heterozygous mouse, whereas wild type genomic DNA was represented by absence of a band. Sex was determined by PCR amplification using the Y-chromosome specific primer set. The presence of a band at 200 bp indicates a male mouse and females are shown as the absence of any product.

Affymetrix expression profiling
-------------------------------

Four *Nf1*^+/-^mice and four age and sex matched wild type mice were analyzed at each time point. Hippocampi (\~20 mg each) from two mice within a single condition were pooled and divided to yield two identical samples, and each was individually extracted, labeled, and hybridized to the Affymetrix (Murine 430 2.0) chip. Total RNA was isolated from each 40 mg tissue sample using Stratagene RTPCR Mini-prep kit (the average yield was 15 μg RNA/40 mg tissue). Extracted RNA was subsequently cleaned using the Qiagen Mini kit protocol, and the purified RNA was analyzed through agarose gel electrophoresis to insure quality.

cDNA was synthesis from 7 μg of purified total RNA, *in vitro*transcription, and hybridization proceeded as previously described \[[@B21]\]. Strict quality controls require that each RNA sample show \>4 × amplification through the *in vitro*transcription protocol, that each scanned array should contain \>30% present calls across the array, and that the 3\'/5\' should show consistent values \>3 indicating low nonspecific hybridization. Arrays that do not satisfy these conditions were not included in the analysis and a second sample of cRNA was created utilizing a second allotment of stored total RNA from the sample.

Data analysis
-------------

Data was extracted from the array images using Affymetrix Microarray Suite version 5.1 software (MAS5.0). Raw expression data was corrected for saturation at individual probes using an in-house Array Data Manipulation program which replaces S2 values with S1 values if the S2 values are greater than 1500 (baseline normalization of 150) or the S2/S1 signal ratio is less than 0.8.

The modified gene expression data for each individual array was imported into GeneSpring v 5.0 (Agilent Technologies). For each time point, average fold changes (relative to wildtype expression data) were calculated with error bars. Genes showing expression changes with significant p-values (p ≤ 0.05) and fold change values of ≥2.0 within at least one time point were exported for functional annotation. Thereafter, the function of each gene was determined through literature searches, genes were binned into ontologic categories, and relevant biological processes and pathways identified.

Modeling the dysfunctional genetic network
------------------------------------------

The main goal of both temporal and functional clustering is to generate an integrated pathway beginning with the known primary genetic defect and ending with proteins known to be involved in causing the cognitive pathology under study. This pathway then becomes the template for later *in vivo*validation. The GeneGo network building algorithms (GeneGo, Inc) were used in an iterative fashion to build gene/protein interaction pathways between known NF1 pathway members (NF1, Ras, GABA) and proteins known to be involved in LTP. The gene expression changes with ≥2 fold differences at p ≤ 0.05 were used to seed the algorithms and identified new pathway members which link the primary defect to the cognitive phenotype. All raw expression data is publicly available \[[@B14],[@B15]\].

Validation of the pathogenic cascade
------------------------------------

*Quantitative Real-Time PCR*-- Total RNA was extracted from \~20 mg of hippocampus from 3 *Nf1*^+/-^and 3 wild type mice using the Absolutely RNA Miniprep Kit (Stratagene). Reverse transcription reactions were done using 3 μg of total RNA from hippocampus, oligo dT primers, and the Super Script III First Strand cDNA synthesis kit (Invitrogen). Resulting cDNA was amplified on the Chromo4 Four-Color Real-Time System (MJ Research) using the DyNAmo HS SYBR Green qPCR Kit (Finnzymes) and gene specific primers. Standardized and optimized primers were ordered from SuperArray Bioscience Corporation. These included primers designed for Stc1 (stanniocalcin1), Htr5a (5-hydroxytryptamine (serotonin) receptor 5A), Neto2 (neuropilin and tolloid like protein 2), and Frap1 (FK506 binding protein 12-rapamycin associated protein1). The housekeeping gene GAPD (glyceraldehydes-3-phosphate dehydrogenase) was analyzed using the primer set (f-CCAGTATGACTCCACTCACG, r-GAGATGATGACCCGTTTGGC). For amplification, the following program was employed: a 95°C heat activation step for 15 min, followed by 40 cycles of 94°C for 10 sec, 55°C for 25 sec, 72°C for 30 sec, incubate at 72°C, and plate reads at both 77°C and 81°C. A melting curve was created evaluating the products between 60--95°C reading every 0.2°C.

Primer set specificity was verified through melting curve analysis. The threshold for amplification was set as the number of cycles necessary to reach logarithmic fluorescence accumulation (C(T)). Fold difference in cDNA concentration was calculated using the formula F = 2^((MH-MG)-(WH-WG))^where F = fold difference, MH = mutant housekeeping gene (GAPD) C(T), MG = mutant gene of interest C(T), WH = wild type housekeeping gene (GAPD) C(T), WG = wild type gene of interest C(T) \[[@B24],[@B25]\]. Statistical significance of the resulting fold change values was calculated with a two-tailed t-test assuming unequal variance.
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Figures and Tables
==================

![**Visualization of all expression fluctuations in the hippocampus across the time series**. Visualization of genes in the second dataset showing a significant (p ≤ 0.05) fold change of ≥2 between *Nf1*^+/-^and wild type mice at one or more time points (n = 163). Genes showing increased expression in the mutant model appear in the red portion of the expression color spectrum with decreasing genes in the green portion. The normalized intensity is plotted on a log scale versus the postnatal age. Each line represents the expression of an individual gene.](1471-2202-7-22-1){#F1}

![**Clustering network connecting neurofibromin primary gene mutation with downstream cellular factors**. Enlargement of signaling network connecting neurofibromin (Nf-1) with the dopamine 3 receptor (D3DR HUMAN) created through the GeneGo networking software. Neurofibromin is indicated as a binding partner for both the kinesin heavy chain and amyliod beta precursor protein (APP). APP binds through integrins to filamin A, a cytoskeletal organizational protein which in turn can bind to and possibly transport the dopamine 3 receptor.](1471-2202-7-22-2){#F2}

###### 

Genes at post natal day 10 showing fold change values of ≥2 between *Nf1*^+/-^and wild type mice (p ≤ 0.05).

  Probe Set       Unigene     Fold Change   P Value    Gene Name                                                                        Gene Symbol
  --------------- ----------- ------------- ---------- -------------------------------------------------------------------------------- -------------
  1421984_at      Mm.20911    12.2          0.00205    stanniocalcin 1                                                                  Stc1
  1422207_at      Mm.4835     9.391         0.000624   5-hydroxytryptamine (serotonin) receptor 5A                                      Htr5a
  1426141_at      Mm.207059   7.518         0.0351     RF-amide G protein-coupled receptor                                              MrgA1
  1445983_at      Mm.172835   6.707         0.0139     ubiquitin-conjugating enzyme E2A, RAD6 homolog                                   Ube2a
  1436615_a\_at   Mm.2611     6.396         0.0416     ornithine transcarbamylase                                                       Otc
  1457713_at      Mm.2213     6.388         0.0281     excision repair cross-complementing rodent repair deficiency                     Ercc5
  1459730_at      Mm.52297    5.653         0.0329     formin binding protein 1                                                         Fnbp1
  1446315_at      Mm.282039   5.376         0.0362     ATP citrate lyase                                                                Acly
  1430486_at      Mm.341756   4.883         0.0493     RAD51-like 1 (S. cerevisiae)                                                     Rad51l1
  1425443_at      Mm.244858   4.441         0.0239     transcription factor AP-2, delta                                                 Tcfap2d
  1452431_s\_at   Mm.235338   4.175         0.0242     histocompatibility 2, class II antigen A, alpha                                  H2-Aa
  1433133_at      Mm.159671   3.708         0.0269     EDAR (ectodysplasin-A receptor)-associated death domain                          Edaradd
  1429566_a\_at   Mm.23790    3.69          0.0369     homeodomain interacting protein kinase 2                                         Hipk2
  1426005_at      Mm.199008   3.673         0.00896    dentin matrix protein 1                                                          Dmp1
  1429668_at      Mm.246550   3.67          0.0389     POU domain, class 4, transcription factor 1                                      Pou4f1
  1415861_at      Mm.30438    3.651         0.0382     tyrosinase-related protein 1                                                     Tyrp1
  1427313_at      Mm.287572   3.557         0.0125     prostaglandin I receptor (IP)                                                    Ptgir
  1435663_at      Mm.9213     3.449         0.00753    estrogen receptor 1 (alpha)                                                      Esr1
  1441957_x\_at   Mm.205196   3.211         0.0202     stromal cell derived factor receptor 1                                           Sdfr1
  1422038_a\_at   Mm.261384   3.19          0.0384     tumor necrosis factor receptor superfamily, member 22                            Tnfrsf22
  1421967_at      Mm.200886   3.031         0.0318     UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 5                 B4galt5
  1419085_at      Mm.41456    2.949         0.0459     Purkinje cell protein 2 (L7)                                                     Pcp2
  1456151_at      Mm.299073   2.931         0.0198     zinc finger protein 358                                                          Zfp358
  1449484_at      Mm.32506    2.929         0.00956    stanniocalcin 2                                                                  Stc2
  1436490_x\_at   Mm.297440   2.888         0.0446     RAN, member RAS oncogene family                                                  Ran
  1447786_at      Mm.86413    2.684         0.0443     pleckstrin homology, Sec7 and coiled-coil domains 1                              Pscd1
  1457684_at      Mm.277465   2.683         0.0331     heat shock protein 12B                                                           Hspa12b
  1437571_at      Mm.261602   2.572         0.023      hypermethylated in cancer 2                                                      Hic2
  1427637_a\_at   Mm.89935    2.516         0.048      desmocollin 3                                                                    Dsc3
  1421275_s\_at   Mm.354761   2.438         0.00644    suppressor of cytokine signaling 7                                               Socs7
  1444641_at      Mm.71996    2.351         0.0412     adenylate cyclase 3                                                              Adcy3
  1459828_at      Mm.1963     2.326         0.00118    serine/arginine repetitive matrix 1                                              Srrm1
  1421660_at      Mm.314531   2.323         0.026      sodium channel, voltage-gated, type IX, alpha polypeptide                        Scn9a
  1445314_at      Mm.4866     2.302         0.000693   ets variant gene 1                                                               Etv1
  1421234_at      Mm.332607   2.248         0.0373     transcription factor 1                                                           Tcf1
  1442456_at      Mm.172679   2.215         0.0262     spermatogenesis associated 5                                                     Spata5
  1441483_at      Mm.336081   2.153         0.0398     SLIT and NTRK-like family, member 2                                              Slitrk2
  1438597_x\_at   Mm.196508   2.137         0.0365     mortality factor 4 like 1                                                        Morf4l1
  1439428_x\_at   Mm.247143   2.118         0.0407     GDP-mannose 4, 6-dehydratase                                                     Gmds
  1459924_at      Mm.340818   2.088         0.0306     ATPase, H+ transporting, lysosomal V0 subunit a isoform 1                        Atp6v0a1
  1425429_s\_at   Mm.354757   2.003         0.048      hypoxia inducible factor 3, alpha subunit                                        Hif3a
  1427040_at      Mm.1314     0.499         0.0418     kidney cell line derived transcript 1                                            Kdt1
  1418745_at      Mm.139817   0.498         0.0139     osteomodulin                                                                     Omd
  1419230_at      Mm.342959   0.49          0.00148    keratin complex 1, acidic, gene 12                                               Krt1-12
  1423170_at      Mm.236009   0.487         0.000269   TAF7 RNA polymerase II, TATA box binding protein (TBP)-associated factor         Taf7
  1419231_s\_at   Mm.342959   0.487         0.00492    keratin complex 1, acidic, gene 12                                               Krt1-12
  1457306_at      Mm.6988     0.483         0.0387     aminolevulinate, delta-, dehydratase                                             Alad
  1432834_at      Mm.24242    0.475         0.00679    carboxypeptidase B2 (plasma)                                                     Cpb2
  1449739_at      Mm.281464   0.472         0.0126     phosphatidylserine synthase 1                                                    Ptdss1
  1460250_at      Mm.43375    0.466         0.00542    sclerostin domain containing 1                                                   Sostdc1
  1425291_at      Mm.4985     0.466         0.00137    forkhead box J1                                                                  Foxj1
  1442344_at      Mm.82680    0.465         0.00971    AP1 gamma subunit binding protein 1                                              Ap1gbp1
  1456247_x\_at   Mm.18565    0.462         0.0237     LIM domain only 6                                                                Lmo6
  1450760_a\_at   Mm.39999    0.462         0.0157     inhibitor of growth family, member 3                                             Ing3
  1418082_at      Mm.10265    0.456         0.0305     N-myristoyltransferase 1                                                         Nmt1
  1427612_at      Mm.171224   0.444         0.00697    defensin beta 9                                                                  Defb9
  1439051_a\_at   Mm.260504   0.442         0.0497     MAP/microtubule affinity-regulating kinase 4                                     Mark4
  1421906_at      Mm.12926    0.427         0.0224     peroxisome proliferator activated receptor binding protein                       Pparbp
  1416203_at      Mm.18625    0.427         0.0261     aquaporin 1                                                                      Aqp1
  1444960_at      Mm.243855   0.412         0.031      cytochrome P450, family 2, subfamily u, polypeptide 1                            Cyp2u1
  1424273_at      Mm.29119    0.402         0.00623    cytochrome P450, family 2, subfamily c, polypeptide 70                           Cyp2c70
  1450995_at      Mm.2135     0.37          0.0443     folate receptor 1 (adult)                                                        Folr1
  1418554_at      Mm.2857     0.366         0.0107     adrenomedullin receptor                                                          Admr
  1424713_at      Mm.28623    0.36          0.0295     calmodulin-like 4                                                                Calml4
  1454866_s\_at   Mm.44747    0.357         0.00964    chloride intracellular channel 6                                                 Clic6
  1449693_at      Mm.258589   0.353         0.0446     mitogen activated protein kinase kinase kinase 7                                 Map3k7
  1452546_x\_at   Mm.221026   0.337         0.0323     defensin beta 11                                                                 Defb11
  1419662_at      Mm.4258     0.332         0.0234     osteoglycin                                                                      Ogn
  1417297_at      Mm.328900   0.294         0.0313     inositol 1,4,5-triphosphate receptor 3                                           Itpr3
  1436477_x\_at   Mm.240224   0.288         0.0103     RAB2, member RAS oncogene family                                                 Rab2
  1459738_x\_at   Mm.1114     0.286         0.0425     galactosidase, alpha                                                             Gla
  1439167_at      Mm.281738   0.284         0.0116     peroxisomal trans-2-enoyl-CoA reductase                                          Pecr
  1420652_at      Mm.216321   0.27          0.0445     arginine-tRNA-protein transferase 1                                              Ate1
  1427560_at      Mm.3410     0.259         0.0328     sine oculis-related homeobox 5 homolog (Drosophila)                              Six5
  1435214_at      Mm.40016    0.241         0.00726    gap junction membrane channel protein alpha 12                                   Gja12
  1425794_at      Mm.209931   0.236         0.0234     polymerase (DNA directed), alpha 2                                               Pola2
  1426151_a\_at   Mm.272264   0.235         0.0214     syntaxin 3                                                                       Stx3
  1439878_at      Mm.207365   0.208         0.0151     involucrin                                                                       Ivl
  1450805_at      Mm.338890   0.202         0.0179     sarcoglycan, delta (dystrophin-associated glycoprotein)                          Sgcd
  1438406_at      Mm.194950   0.195         0.00559    scavenger receptor class F, member 2                                             Scarf2
  1439457_x\_at   Mm.9852     0.189         0.0278     autophagy 12-like (S. cerevisiae)                                                Apg12l
  1444680_at      Mm.208970   0.171         0.0137     positive cofactor 2, multiprotein complex, glutamine/Q-rich-associated protein   Pcqap
  1426171_x\_at   Mm.193478   0.17          0.0166     killer cell lectin-like receptor, subfamily A, member 7                          Klra7
  1418618_at      Mm.2657     0.0828        6.20E-05   engrailed 1                                                                      En1

###### 

Genes at post natal day 15 showing fold change values of ≥2 between *Nf1*^+/-^and wild type mice (p ≤ 0.05)

  Probe Set       Unigene     Fold Change   P Value    Gene Name                                                                             Gene Symbol
  --------------- ----------- ------------- ---------- ------------------------------------------------------------------------------------- -------------
  1425754_a\_at   Mm.1420     12.45         0.0354     butyrophilin, subfamily 1, member A1                                                  Btn1a1
  1418555_x\_at   Mm.21642    6.649         0.00469    Spi-C transcription factor (Spi-1/PU.1 related)                                       Spic
  1420992_at      Mm.10279    6.523         0.00774    ankyrin repeat domain 1 (cardiac muscle)                                              Ankrd1
  1418358_at      Mm.331192   6.182         0.0229     mitochondrial capsule selenoprotein                                                   Mcsp
  1458958_at      Mm.209041   6.01          0.00798    neighbor of Punc E11                                                                  Nope
  1447392_s\_at   Mm.276736   5.357         0.0228     carboxypeptidase D                                                                    Cpd
  1450439_at      Mm.248353   5.224         0.0198     host cell factor C1                                                                   Hcfc1
  1435410_at      Mm.159608   4.96          0.0419     testicular cell adhesion molecule 1                                                   Tcam1
  1454032_at      Mm.126079   4.831         0.0386     neuropilin (NRP) and tolloid (TLL)-like 2                                             Neto2
  1438414_at      Mm.39703    4.337         0.0381     fukutin related protein                                                               Fkrp
  1420652_at      Mm.216321   4.245         0.0175     arginine-tRNA-protein transferase 1                                                   Ate1
  1425069_at      Mm.264252   4.15          0.00663    similar to nuclear protein, 25 K -- mouse                                             LOC223706
  1421515_at      Mm.242728   3.998         0.0161     nuclear receptor subfamily 6, group A, member 1                                       Nr6a1
  1447362_at      Mm.29133    3.983         0.04       budding uninhibited by benzimidazoles 1 homolog, beta                                 Bub1b
  1456697_x\_at   Mm.22480    3.814         0.0171     cyclin D binding myb-like transcription factor 1                                      Dmtf1
  1422260_x\_at   Mm.14302    3.75          0.0144     chemokine (C-C motif) receptor 5                                                      Ccr5
  1420253_at      Mm.201322   3.638         0.0362     dolichol-phosphate (beta-D) mannosyltransferase 1                                     Dpm1
  1427825_at      Mm.272223   3.568         0.0202     solute carrier organic anion transporter family, member 1b2                           Slco1b2
  1458678_at      Mm.347976   3.356         0.00654    NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1                           Ndufab1
  1441659_at      Mm.151308   3.305         0.0274     D4, zinc and double PHD fingers, family 3                                             Dpf3
  1417015_at      Mm.41265    3.094         0.0256     Ras association (RalGDS/AF-6) domain family 3                                         Rassf3
  1418536_at      Mm.34421    3.034         0.0147     histocompatibility 2, Q region locus 7                                                H2-Q7
  1437847_x\_at   Mm.28275    2.999         0.0357     RNA binding motif protein, X chromosome                                               Rbmx
  1440837_at      Mm.358604   2.771         0.031      histocompatibility 2, O region beta locus                                             H2-Ob
  1418595_at      Mm.12966    2.751         0.041      plasma membrane associated protein, S3-12                                             S3-12
  1422278_at      Mm.327835   2.707         0.00471    dopamine receptor 3                                                                   Drd3
  1425398_at      Mm.371766   2.539         0.0134     histone 1, H2bc                                                                       Hist1h2bc
  1425443_at      Mm.244858   2.53          0.0347     transcription factor AP-2, delta                                                      Tcfap2d
  1419623_at      Mm.86657    2.515         0.0308     protease, serine, 21                                                                  Prss21
  1421359_at      Mm.57199    2.51          0.000164   ret proto-oncogene                                                                    Ret
  1450455_s\_at   Mm.89993    2.504         0.00985    aldo-keto reductase family 1, member C12                                              Akr1c12
  1420710_at      Mm.4869     2.422         0.0149     reticuloendotheliosis oncogene                                                        Rel
  1434885_at      Mm.155687   2.357         0.0457     DNA segment, Chr 7, ERATO Doi 413, expressed                                          D7Ertd413e
  1451463_at      Mm.291372   2.351         0.0344     Rho GTPase activating protein 8                                                       Arhgap8
  1416309_at      Mm.290015   2.299         0.00369    nucleolar and spindle associated protein 1                                            Nusap1
  1425064_at      Mm.250265   2.272         0.00144    aryl hydrocarbon receptor nuclear translocator                                        Arnt
  1425721_at      Mm.221688   2.245         0.0475     pleckstrin homology domain interacting protein                                        Phip
  1421953_at      Mm.21048    2.219         0.0017     v-crk sarcoma virus CT10 oncogene homolog (avian)-like                                Crkl
  1426520_at      Mm.104932   2.199         0.0211     B-cell translocation gene 4                                                           Btg4
  1450104_at      Mm.3037     2.172         0.0339     a disintegrin and metalloprotease domain 10                                           Adam10
  1436008_at      Mm.371590   2.134         0.00836    tumor protein D52                                                                     Tpd52
  1419535_at      Mm.263706   2.121         0.0243     solute carrier organic anion transporter family, member 6b1                           Slco6b1
  1420499_at      Mm.10651    2.121         0.0318     GTP cyclohydrolase 1                                                                  Gch
  1451870_a\_at   Mm.253518   2.011         0.0256     bromodomain containing 4                                                              Brd4
  1445886_at      Mm.4454     0.497         0.0367     ELK3, member of ETS oncogene family                                                   Elk3
  1425690_at      Mm.218788   0.461         0.0463     beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)                          B3gat1
  1441966_at      Mm.124567   0.452         0.0279     transient receptor potential cation channel, subfamily M, member 3                    Trpm3
  1427635_at      Mm.30355    0.438         0.0348     kinesin family member 5A                                                              Kif5a
  1418194_at      Mm.271670   0.421         0.0445     UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 10   Galnt10
  1416239_at      Mm.3217     0.42          0.00011    argininosuccinate synthetase 1                                                        Ass1
  1449266_at      Mm.131408   0.415         0.0128     methyl CpG binding protein 2                                                          Mecp2
  1440072_at      Mm.210787   0.407         0.021      glucocorticoid induced transcript 1                                                   Glcci1
  1430357_at      Mm.371563   0.398         0.0139     H3 histone, family 3B                                                                 H3f3b
  1425707_a\_at   Mm.328720   0.387         0.0192     potassium inwardly-rectifying channel, subfamily J, member 6                          Kcnj6
  1446185_at      Mm.21158    0.353         0.0479     FK506 binding protein 12-rapamycin associated protein 1                               Frap1
  1422144_at      Mm.3510     0.328         0.0259     inhibin beta E                                                                        Inhbe
  1421447_at      Mm.303355   0.298         0.000377   one cut domain, family member 1                                                       Onecut1
  1449907_at      Mm.174133   0.255         0.0278     beta-carotene 15, 15\'-dioxygenase 1                                                  Bcdo1
  1421073_a\_at   Mm.18509    0.237         0.0359     prostaglandin E receptor 4 (subtype EP4)                                              Ptger4
  1420296_at      Mm.254370   0.232         0.00578    chloride channel 5                                                                    Clcn5
  1418158_at      Mm.20894    0.205         0.0342     transformation related protein 63                                                     Trp63
  1448074_at      Mm.5033     0.174         0.0361     relaxin 1                                                                             Rln1
  1453630_at      Mm.271953   0.122         0.00471    UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 14   Galnt14
  1446162_at      Mm.125979   0.0938        0.0101     poly A binding protein, cytoplasmic 5                                                 Pabpc5

###### 

Genes at post natal day 20 showing fold change values of ≥2 between *Nf1*^+/-^and wild type mice (p ≤ 0.05)

  Probe Set       Unigene     Fold Change   P Value    Gene Name                                                              Gene Symbol
  --------------- ----------- ------------- ---------- ---------------------------------------------------------------------- -------------
  1425947_at      Mm.240327   13.26         0.000122   interferon gamma                                                       Ifng
  1442827_at      Mm.38049    4.568         0.0446     toll-like receptor 4                                                   Tlr4
  1425478_x\_at   Mm.240044   4.347         0.0178     ubiquitin-conjugating enzyme E2I                                       Ube2i
  1450337_a\_at   Mm.23788    3.618         0.0132     NIMA (never in mitosis gene a)-related expressed kinase 8              Nek8
  1422411_s\_at   Mm.327088   3.478         0.0376     ribonuclease, RNase A family 3                                         Rnase3
  1422297_at      Mm.158264   2.727         0.0381     prefoldin 5                                                            Pfdn5
  1438564_at      Mm.207360   2.573         0.0405     growth arrest specific 2                                               Gas2
  1433732_x\_at   Mm.281018   2.313         0.0229     insulin-like growth factor 2, binding protein 3                        Igf2bp3
  1427816_at      Mm.21841    2.306         0.0137     splicing factor, arginine/serine-rich 2 (SC-35)                        Sfrs2
  1452349_x\_at   Mm.255414   2.149         0.0043     interferon activated gene 205                                          Ifi205
  1418604_at      Mm.4351     2.038         0.0134     arginine vasopressin receptor 1A                                       Avpr1a
  1438156_x\_at   Mm.18522    0.496         0.0254     carnitine palmitoyltransferase 1a, liver                               Cpt1a
  1426714_at      Mm.131618   0.488         0.00577    DNA segment, Chr 11, ERATO Doi 18                                      D11Ertd18e
  1455332_x\_at   Mm.330161   0.48          0.00869    Fc receptor, IgG, low affinity IIb                                     Fcgr2b
  1450951_at      Mm.14910    0.478         0.0373     chondroitin sulfate proteoglycan 6                                     Cspg6
  1423719_at      Mm.3783     0.359         0.0127     cDNA sequence U46068                                                   U46068
  1419109_at      Mm.39968    0.357         0.0432     histidine rich calcium binding protein                                 Hrc
  1460746_at      Mm.236114   0.356         0.0339     fidgetin-like 1                                                        Fignl1
  1433382_at      Mm.79127    0.352         0.0427     dynein, axonemal, intermediate chain 1                                 Dnaic1
  1449207_a\_at   Mm.258846   0.297         0.0232     kinesin family member 20A                                              Kif20a
  1455990_at      Mm.259374   0.279         0.00332    kinesin family member 23                                               Kif23
  1436682_at      Mm.3532     0.273         0.0428     thymosin, beta 10                                                      Tmsb10
  1430486_at      Mm.341756   0.232         0.0143     RAD51-like 1 (S. cerevisiae)                                           Rad51l1
  1426598_at      Mm.20477    0.222         0.0128     ubiquitously transcribed tetratricopeptide repeat gene, Y chromosome   Uty
  1451463_at      Mm.291372   0.193         0.0173     Rho GTPase activating protein 8                                        Arhgap8
  1441429_at      Mm.261591   0.188         0.036      insulin receptor substrate 4                                           Irs4
  1452563_a\_at   Mm.262676   0.109         0.00609    selected mouse cDNA on the Y                                           Smcy
  1457582_at      Mm.20477    0.0739        0.0209     ubiquitously transcribed tetratricopeptide repeat gene, Y chromosome   Uty
  1426438_at      Mm.302938   0.0533        0.0444     DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, Y-linked                     Ddx3y

###### 

Affymetrix and RT-PCR fold change values for genes significantly regulated in the hippocampus of *Nf1*^+/-^mice

  Gene Symbol   Gene Name                                                Probe ID     Fold Change   P-value   RT-PCR Fold Change   RT-PCR P-value
  ------------- -------------------------------------------------------- ------------ ------------- --------- -------------------- ----------------
  Stc1          stanniocalcin 1                                          1421984_at   12.2          0.0021    1.7592               0.0100
  Htr5a         5-hydroxytryptamine (serotonin) receptor 5A              1422207_at   9.391         0.0006    2.0005               0.0580
  Neto2         neuropilin (NRP) and tolloid (TLL)-like 2                1454032_at   4.831         0.0386    1.4045               0.0415
  Frap1         FK506 binding protein12-rapamycin associated protein 1   1446185_at   0.353         0.0479    0.3927               0.4711
